Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

KalVista Pharmaceuticals (KALV) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for KalVista Pharmaceuticals (KALV) over the last 9 years, with Q2 2025 value amounting to $2.0 million.

  • KalVista Pharmaceuticals' Interest & Investment Income rose 3165.9% to $2.0 million in Q2 2025 from the same period last year, while for Apr 2025 it was $5.9 million, marking a year-over-year increase of 10057.98%. This contributed to the annual value of $6.4 million for FY2025, which is 6516.94% up from last year.
  • Latest data reveals that KalVista Pharmaceuticals reported Interest & Investment Income of $2.0 million as of Q2 2025, which was up 3165.9% from $1.7 million recorded in Q3 2024.
  • KalVista Pharmaceuticals' Interest & Investment Income's 5-year high stood at $2.0 million during Q2 2025, with a 5-year trough of $684000.0 in Q1 2024.